Patents Assigned to Bioption
  • DNA expression systems based on alphaviruses
    Patent number: 6190666
    Abstract: The disclosure describes recombinant alphavirus RNA molecules and expression of heterologous proteins therefrom in animal cells. Recombinant alphaviruses of the present invention, when made to express an antigenic protein, can be administered as vaccines.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: February 20, 2001
    Assignee: Bioption
    Inventors: Henrik Garoff, Peter Liljeström